MARKET WIRE NEWS

EssilorLuxottica (ESLOF) Q2 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-07-28 17:22:16 ET

EssilorLuxottica (ESLOF)

Q2 2025 Earnings Conference Call

July 28 2025, 12:30 PM ET

Company Participants

Francesco Milleri - Non-Independent Chairman & CEO

Giorgio Iannella - Head of Investor Relations

Paul du Saillant - Deputy CEO & Non-Independent Director

Stefano Grassi - Chief Financial Officer

Conference Call Participants

Chiara Battistini - JPMorgan Chase & Co, Research Division

Domenico Ghilotti - Equita SIM S.p.A., Research Division

Hugo Solvet - BNP Paribas Exane, Research Division

Julien Dormois - Jefferies LLC, Research Division

Louise Susan Singlehurst - Goldman Sachs Group, Inc., Research Division

Luca Giuseppe Solca - Sanford C. Bernstein & Co., LLC., Research Division

Oriana Cardani - Intesa Sanpaolo Equity Research

Veronika Dubajova - Citigroup Inc., Research Division

Presentation

Giorgio Iannella

Good morning, and good afternoon, everybody. This is Giorgio Iannella from the IR team. Thank you for joining EssilorLuxottica Interim Results Management Call. The Group Chairman and CEO, Francesco Milleri; the Deputy CEO, Paul du Saillant; and the CFO, Stefano Grassi, will walk you through the business and financial highlights of the first half of the year. After their presentations, there will be a 30-minute Q&A session. [Operator Instructions] With that, I hand over to Francesco.

Francesco Milleri

Welcome, everyone. I'm pleased to reconnect with you to share our first half financial results and update you on our progress in MedTech and wearable. Let's begin with our long-term vision....

Read the full article on Seeking Alpha

For further details see:

EssilorLuxottica (ESLOF) Q2 2025 Earnings Call Transcript
EssilorLuxottica

NASDAQ: ESLOF

ESLOF Trading

-5.09% G/L:

$232.40 Last:

642 Volume:

$246.72 Open:

mwn-link-x Ad 300

ESLOF Latest News

ESLOF Stock Data

$133,939,122,404
445,231,933
N/A
1153
N/A
Medical Equipment & Supplies
Healthcare
FR
Paris

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App